Takenobu Y, Kikuchi T, Ishikawa D, et al. Rozanolixizumab as rescue therapy in triple seronegative refractory generalized ...
Misoprostol-only abortion is not a medical advancement. It is an inferior, failure-prone protocol promoted for its supposed convenience rather than its safety and effectiveness. To start, misoprostol ...
Intravenous immunoglobulin (IVIG) therapy involves infusing patients with naturally occurring IgG antibodies to treat autoimmune conditions. With origins dating back to the 1950s, IVIG is currently ...
India's Immunoglobulin Market is expected to reach US$ 1.22 billion by 2033 from US$ 347 million in 2024, with a CAGR of 15% from 2025 to 2033. The rising prevalence of immunodeficiency disorders, ...
Measles is popping up in pockets across the country, and with holiday travel and colder weather setting in, it’s time to be ...
Pharmaceutical Technology on MSN
CSL to pump $1.5bn into US plasma supply chain
CSL said the investment reflects the growing need for immunoglobulin, though it did not reveal detailed manufacturing plans.
About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top ...
A multidisciplinary panel of medical oncology, dermatology, gastroenterology, rheumatology, pulmonology, endocrinology, neurology, hematology, emergency medicine ...
Aimovig is a brand-name medication that is prescribed to prevent migraine episodes in adults. It is administered via injection, not for treating symptoms as they occur. Common side effects of Aimovig ...
A baby formula brand has issued an urgent recall after a dangerous bacteria was found in its products, leading to multiple hospitalizations across the country. ByHeart, based in Reading, Pennsylvania, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results